C1FMU2 AF NFT

30S ribosomal protein S17

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicvtwndd3slvyjodl4ud6pd46mhwfuiyrck5mt7mpewz33j4ty2i4/metadata.json
IPFS of structure file: 
bafybeiezjxttvngwckuya556vbk4aadtwsvygjg4qks7otgeihexp5m7cy/AF-C1FMU2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x1ED4a68B4011314730adE976b56Ad4cA21b54dcD
First NFT owner address (bech32): 
genesis1rm22dz6qzyc5wv9da9mt26k5egsm2nwdw6hzk8
Current NFT ID #399616 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
399616
Accession (UniProt):
C1FMU2
Name::
30S ribosomal protein S17
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN KYOTO / TYPE A2)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT C1FMU2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|C1FMU2|RS17_CLOBJ 30S ribosomal protein S17 OS=Clostridium botulinum (strain Kyoto / Type A2) OX=536232 GN=rpsQ PE=3 SV=1 MERSNRKTRIGRVVSNKMDKTIVVAVETKVRHPLYGKIMNRTTKFKAHDENNAANINDKVLIMETRPLSKQKRWRLVEVVEKAK